Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above
CompanyDrug

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its wholly‑owned subsidiary, Xiamen Innovax Biotech Co., Ltd., has received the Drug Clinical Trial Approval Notice from China's National…

Sansure Biotech's Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

Sansure Biotech’s Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

Guangdong True Health Medical's Gene‑Edited Pig Liver Perfusion Support Sets 144‑Hour Global Record – World's First Prolonged Xenotransplantation Efficacy Validation in Preclinical Acute Liver Failure Model

Guangdong True Health Medical’s Gene‑Edited Pig Liver Perfusion Support Sets 144‑Hour Global Record – World’s First Prolonged Xenotransplantation Efficacy Validation in Preclinical Acute Liver Failure Model

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyMedical Device

BGI Genomics Receives NMPA Approval for Chromosome Aneuploidy Detection Kit

CompanyDrug

Novartis’ Cosentyx Gains Approval for New Doses in China

CompanyDrug

NMPA Approves Kyowa Hakko Kirin’s Mogamulizumab for Sezary Syndrome and Mycosis Fungoides

CompanyDrug

NMPA Grants Second Approval to Henlius’ Serplulimab for Lung Cancer

CompanyDrug

Innovent’s Tyvyt Approved for New Gastric Cancer Indication by NMPA

CompanyDrug

Zhejiang Huahai Receives FDA ANDA Approval for Generic Tecfidera

CompanyDrug

BeiGene’s Brukinsa Receives Multiple Marketing Approvals in Latin America

CompanyMedical Device

AccuMedical’s Blood Flow-Guided Stent Wins NMPA Approval for Brain Aneurysms

Show More